scholarly journals Two‐stage design for phase I–II cancer clinical trials using continuous dose combinations of cytotoxic agents

2018 ◽  
Vol 68 (1) ◽  
pp. 235-250 ◽  
Author(s):  
Mourad Tighiouart
Biometrics ◽  
1989 ◽  
Vol 45 (2) ◽  
pp. 537 ◽  
Author(s):  
Peter F. Thall ◽  
Richard Simon ◽  
Susan S. Ellenberg

Sign in / Sign up

Export Citation Format

Share Document